
|Articles|January 15, 2004
Choice of medication should be determined case by case
Author(s)Nancy Groves
Philadelphia-In about 80% of glaucoma cases, medication is the preferred initial approach for lowering IOP. However, the choice of medication must be made with the cognition of individual patient differences that can affect the tolerability and effectiveness of the drug, noted Marlene Moster, MD, clinical professor of ophthalmology, Thomas Jefferson Medical Col- lege, Philadelphia.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy
2
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
3
Glaucoma innovation: Eight themes to watch in 2026
4
Ocugen publishes phase 1 GARDian1 gene therapy data for Stargardt disease
5












































